News summary

Eos puts new gerotherapeutic to the test in aging mice

Source: Longevity Technology • Published: 22 Oct 2026, 07:25

Summarized by Masters of Longevity from Longevity Technology.

Report on preclinical results presented at a mitochondrial congress showing a mitochondrial-targeted geropeptide improved survival, activity and metabolic measures in naturally aged mice.

Eos puts new gerotherapeutic to the test in aging mice
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.